 Connection
Amanda Wieland to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Amanda Wieland has written about Non-alcoholic Fatty Liver Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.589 |
|
|
|
-
Wieland A, Kohli R. Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends. Am J Gastroenterol. 2018 11; 113(11):1588-1589.
Score: 0.469
-
Wieland A, Frank DN, Harnke B, Bambha K. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2015 Nov; 42(9):1051-63.
Score: 0.377
-
Wieland AC, Mettler P, McDermott MT, Crane LA, Cicutto LC, Bambha KM. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol. 2015 Jan; 49(1):e6-e10.
Score: 0.360
-
Maier S, Wieland A, Cree-Green M, Nadeau K, Sullivan S, Lanaspa MA, Johnson RJ, Jensen T. Lean NAFLD: an underrecognized and challenging disorder in medicine. Rev Endocr Metab Disord. 2021 06; 22(2):351-366.
Score: 0.137
-
Jensen T, Wieland A, Cree-Green M, Nadeau K, Sullivan S. Clinical workup of fatty liver for the primary care provider. Postgrad Med. 2019 Jan; 131(1):19-30.
Score: 0.118
-
Wieland AC, Quallick M, Truesdale A, Mettler P, Bambha KM. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2013 Oct; 58(10):2809-16.
Score: 0.081
-
Lindsay M, Arndt G, Wieland A, Jensen T. Evolving Role of GLP-1 Therapies in Liver Disease. Curr Gastroenterol Rep. 2025 Jun 06; 27(1):36.
Score: 0.046
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|